Literature DB >> 21686130

Tumour necrosis factor-α (TNF-α) and miRNA expression in frontal and temporal neocortex in Alzheimer's disease and the effect of TNF-α on miRNA expression in vitro.

Doris Culpan1, Patrick G Kehoe, Seth Love.   

Abstract

Micro-RNAs (miRNAs) are short non-coding RNAs capable of regulating gene expression at the translational level. A number of studies have suggested that the expression of several miRNAs is changed in AD. The pro-inflammatory cytokine tumour necrosis factor-a (TNF-α) is increased in serum and CSF in AD. We measured the expression of TNFA and several AD candidate gene-associated miRNAs (let7a/b, miR-128a/b, miR-27a/b, miR-155) in frontal and temporal neocortex from AD and control brains. The expression of these miRNAs was also measured after incubating non-differentiated (NDC) and retinoic acid -differentiated (DC) SH-SY5Y neuroblastoma cells with TNF-α. TNFA expression was similar in AD and control brains but miR-128a/b levels were significantly reduced in the temporal cortex and miR-128b in the frontal cortex in AD. MiRNA levels did not correlate with TNFA expression in brain tissue but exposure of NDC and DC SH-SY5Y cells to TNF-α caused a variable dose-dependent response in the level of some of the miRNAs studied. Our brain tissue findings argue against a role for TNF-α in influencing the expression of these miRNAs in AD.

Entities:  

Keywords:  Alzheimer's disease; SH-SY5Y cells; Tumour necrosis factor-a; microRNA

Year:  2011        PMID: 21686130      PMCID: PMC3110390     

Source DB:  PubMed          Journal:  Int J Mol Epidemiol Genet        ISSN: 1948-1756


  48 in total

Review 1.  Transcription and processing of human microRNA precursors.

Authors:  Bryan R Cullen
Journal:  Mol Cell       Date:  2004-12-22       Impact factor: 17.970

2.  Proinflammatory cytokines in sera of elderly patients with dementia: levels in vascular injury are higher than those of mild-moderate Alzheimer's disease patients.

Authors:  Roberto Paganelli; Angelo Di Iorio; Luca Patricelli; Fausto Ripani; Eleonora Sparvieri; Raffaella Faricelli; Carla Iarlori; Ettore Porreca; Mario Di Gioacchino; Giuseppe Abate
Journal:  Exp Gerontol       Date:  2002 Jan-Mar       Impact factor: 4.032

Review 3.  The biology of cachectin/TNF--a primary mediator of the host response.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

4.  Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.

Authors:  Lauren M Billings; Salvatore Oddo; Kim N Green; James L McGaugh; Frank M LaFerla
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

5.  MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1.

Authors:  Vincent Boissonneault; Isabelle Plante; Serge Rivest; Patrick Provost
Journal:  J Biol Chem       Date:  2008-11-05       Impact factor: 5.157

Review 6.  MicroRNAs (miRNAs) in neurodegenerative diseases.

Authors:  Peter T Nelson; Wang-Xia Wang; Bernard W Rajeev
Journal:  Brain Pathol       Date:  2008-01       Impact factor: 6.508

7.  Post-transcriptional regulation of miR-27 in murine cytomegalovirus infection.

Authors:  Amy H Buck; Jonathan Perot; Michael A Chisholm; Diwakar S Kumar; Lee Tuddenham; Valérie Cognat; Lisa Marcinowski; Lars Dölken; Sébastien Pfeffer
Journal:  RNA       Date:  2010-01-04       Impact factor: 4.942

Review 8.  Angiotensins in Alzheimer's disease - friend or foe?

Authors:  Patrick G Kehoe; Scott Miners; Seth Love
Journal:  Trends Neurosci       Date:  2009-09-30       Impact factor: 13.837

9.  MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction.

Authors:  Jannet Kocerha; Mohammad Ali Faghihi; Miguel A Lopez-Toledano; Jia Huang; Amy J Ramsey; Marc G Caron; Nicole Sales; David Willoughby; Joacim Elmen; Henrik F Hansen; Henrik Orum; Sakari Kauppinen; Paul J Kenny; Claes Wahlestedt
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

Review 10.  Computational challenges in miRNA target predictions: to be or not to be a true target?

Authors:  Christian Barbato; Ivan Arisi; Marcos E Frizzo; Rossella Brandi; Letizia Da Sacco; Andrea Masotti
Journal:  J Biomed Biotechnol       Date:  2009-06-17
View more
  11 in total

Review 1.  Epigenomics of Alzheimer's disease.

Authors:  David A Bennett; Lei Yu; Jingyun Yang; Gyan P Srivastava; Cristin Aubin; Philip L De Jager
Journal:  Transl Res       Date:  2014-05-16       Impact factor: 7.012

2.  A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer's Disease.

Authors:  Soraya Herrera-Espejo; Borja Santos-Zorrozua; Paula Álvarez-González; Elixabet Lopez-Lopez; África Garcia-Orad
Journal:  Mol Neurobiol       Date:  2019-06-25       Impact factor: 5.590

3.  Post-mortem analysis of neuroinflammatory changes in human Alzheimer's disease.

Authors:  Diego Gomez-Nicola; Delphine Boche
Journal:  Alzheimers Res Ther       Date:  2015-04-22       Impact factor: 6.982

Review 4.  miR-155 is involved in Alzheimer's disease by regulating T lymphocyte function.

Authors:  Juhyun Song; Jong Eun Lee
Journal:  Front Aging Neurosci       Date:  2015-04-30       Impact factor: 5.750

5.  Differentiation impairs Bach1 dependent HO-1 activation and increases sensitivity to oxidative stress in SH-SY5Y neuroblastoma cells.

Authors:  Sabrina Piras; Anna Lisa Furfaro; Lorenzo Brondolo; Mario Passalacqua; Umberto Maria Marinari; Maria Adelaide Pronzato; Mariapaola Nitti
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

6.  Differences in Immune-Related Genes Underlie Temporal and Regional Pathological Progression in 3xTg-AD Mice.

Authors:  Adelaide Fernandes; Cláudia Caldeira; Carolina Cunha; Elisabete Ferreiro; Ana Rita Vaz; Dora Brites
Journal:  Cells       Date:  2022-01-01       Impact factor: 6.600

Review 7.  Is there a causal link between inflammation and dementia?

Authors:  Ana-Maria Enciu; Bogdan O Popescu
Journal:  Biomed Res Int       Date:  2013-06-06       Impact factor: 3.411

8.  Non-Coding RNAs: Functional Aspects and Diagnostic Utility in Oncology.

Authors:  Taiho Kim; Armin Reitmair
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

9.  Variability in micro RNA (miRNA) abundance, speciation and complexity amongst different human populations and potential relevance to Alzheimer's disease (AD).

Authors:  Walter J Lukiw
Journal:  Front Cell Neurosci       Date:  2013-08-27       Impact factor: 5.505

Review 10.  Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease.

Authors:  Alex Cleber Improta-Caria; Carolina Kymie Vasques Nonaka; Bruno Raphael Ribeiro Cavalcante; Ricardo Augusto Leoni De Sousa; Roque Aras Júnior; Bruno Solano de Freitas Souza
Journal:  Int J Mol Sci       Date:  2020-07-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.